Pharma News

New Study Highlights Promise of Direct-To-Consumer Models That Facilitate Access to Anti-Obesity Medications

Researchers highlight several benefits and concerns associated with the launch of direct-to-consumer models for GLP-1 receptor agonists.

Source link
#Study #Highlights #Promise #DirectToConsumer #Models #Facilitate #Access #AntiObesity #Medications

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *